Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2024 Dec 2.
Published in final edited form as: Am J Ind Med. 2024 Oct 25;67(12):1089–1107. doi: 10.1002/ajim.23669

Functional Disabilities and Adverse Well-being by COVID-19 and Long COVID History and Employment Status: 2022 Behavioral Risk Factor Surveillance System

SR Silver 1, J Li 1, ND Ford 2, SH Saydah 2
PMCID: PMC11609551  NIHMSID: NIHMS2031800  PMID: 39450880

Abstract

BACKGROUND

Long COVID can lead to functional disabilities and decreased well-being and limit the ability to work. No study has yet assessed associations of SARS-CoV-2-infection and Long COVID with specific measures of well-being and functional disabilities among workers by employment status.

METHODS

Using data from the U.S. Behavioral Risk Factor Surveillance System, we assessed prevalences of functional disabilities and well-being measures among adults of prime working age (25–54 years) by employment status and self-reported COVID-19 and Long COVID history. Within each employment status, we generated adjusted prevalence ratios (aPRs) comparing respondents from each 2022 COVID-19/Long COVID category to respondents in that employment status before the pandemic (2019).

RESULTS

In 2022, prevalences of each functional disability except vision and all adverse mental well-being measures were highest among the 9.2% of respondents reporting a history of Long COVID. Prevalences of all outcomes were lowest for workers and highest among those unable to work. 2022 prevalences of cognitive disability (16.4% of employees, 21.4% of the self-employed) and depression (31.2% and 36.4%, respectively) among workers reporting a history of Long COVID were more than double 2019 levels. Increases in cognitive disability and depression were lower but statistically significant among workers not reporting a history of Long COVID.

CONCLUSIONS

High prevalences of functional disabilities and adverse well-being among workers reporting a history of Long COVID have implications for workers and employers. Also concerning are smaller increases among workers not reporting a history of Long COVID, given the large number of affected workers. Mitigating the effects of Long COVID on workers will involve efforts in multiple domains: reducing incidence, increasing healthcare practitioner awareness, improving diagnosis and treatments, and increasing employer awareness of best practices for accommodating workers with Long COVID.

Keywords: COVID-19, Long COVID, employment, unemployment, disability, wellbeing

INTRODUCTION

Long COVID (also referred to as Post-COVID Conditions) comprises a large array of symptoms and incident diagnoses affecting multiple organ systems1,2 and can lead to decreased well-being and functional limitations.35 In some cases, limitations associated with Long COVID affect the ability to work, leading to changes in jobs or job duties, reduction in hours, increased need for workplace accommodations, and, in severe cases, exit from the labor market.2,611

Quantitative estimates of the impact of Long COVID on employment differ by study timing and design, Long COVID definition and ascertainment, type of work, and other considerations.12,13 A mid-2022 report using Household Pulse Survey data estimated that 2–4 million Americans were out of the labor force due to Long COVID.6 Small studies of Long COVID clinic patients in the European Union and the United Kingdom have assessed the effects of Long COVID on work. Findings include that half of patients were no longer working or had reduced working hours and, therefore, reduced income.9 Further, the inability to work was associated with higher levels of fatigue and many employed patients were having difficulty at work due to their symptoms.7 In addition, among working-aged patients with physical complaints, health-related quality of life and self-reported ability to work were lower compared to the general public.14 Moreover, a U.S. study found increased economic hardship among families in which the head of household had Long COVID, regardless of pre-pandemic income level.15

A report using Federal Reserve Economic Database (FRED) data noted that while the number of Americans with disabilities has risen, the number of labor force participants with disabilities has increased more sharply.6 An analysis of Current Population Survey (CPS) data comparing the pre-pandemic period (2017–2019) to 2022 found that the increase in the number of people working with a disability was greater than the number of labor-market departures attributable to Long COVID.3 Further, a comparison of CPS data from Q1 2020 to Q2 2022 found that levels of employment and labor-market participation increased among adults aged 18–64 years with functional disabilities but not among those without disabilities.16 At the same time, declines in well-being and health-related quality of life have been noted among people with Long COVID4,5 and could affect the ability of those affected to remain fully employed.

To date, no study has assessed the impact of COVID-19 illness and Long COVID on specific measures of well-being and functional disabilities across employment status: employed, self-employed, out of work (short-term and long-term), and unable to work. A number of key questions are unanswered: Do those currently working have higher prevalences of functional disabilities and adverse well-being than pre-pandemic workforces? Do the short-term unemployed, long-term unemployed, and those who report they are unable to work face higher prevalences of conditions that might make re-employment more difficult? How do the answers to these questions differ by history of COVID-19 illness and Long COVID? This information is key to understanding impacts of COVID-19 and Long COVID on the labor market and the workforce.

The Behavioral Risk Factor Surveillance System (BRFSS) presents an opportunity to address these questions by 1) assessing prevalences of select well-being and functional disability measures by employment status among 2022 BRFSS respondents of prime working age (25 to 54 years) by COVID-19 and Long COVID histories and 2) comparing prevalences of well-being and functional disability measures to those in the pre-pandemic (2019) population.

METHODS

Data source

BRFSS is an annual, state-based, nationally representative survey of the non-institutionalized U.S. civilian population aged 18 years and older. All states, the District of Columbia, and select territories conduct the study, using random-digit dialed landline and cellular telephone calls, to collect self-reported information about healthcare access, health-related risk behaviors, and health outcomes. In 2019, New Jersey was unable to collect enough data to meet requirements for inclusion in the aggregated, national dataset, and the U.S. Virgin Islands did not participate that year. Median BRFSS response rates across states and territories were 53.3% for landline and 45.9% for cellphone in 2019 and 46.3% for landline and 44.7% for cellphone in 2022. Response rates overall and by the state are found at https://www.cdc.gov/brfss/data_documentation/index.htm.

BRFSS was reviewed by the Human Research Protection Office of the Centers for Disease Control and Prevention and determined to be exempt research. Survey information was collected under OMB control number 0920–1061.

Employment Status and Inclusion Criteria

The core survey includes a question about employment: “Are you currently employed for wages, self-employed, out of work for 1 year or more, out of work for less than 1 year, a student, a homemaker, retired, or unable to work?” We included in our study population respondents who reported their employment status as employed for wages (henceforth “employed”), self-employed (“self-employed”), out of work less than 1 year (“short-term unemployed”), out of work for 1 year or more (“long-term unemployed”), and unable to work (“unable to work”). BRFSS does not ask whether those who report not working are currently looking for work; “unemployment” is used here as shorthand for “not working” rather than to indicate labor market engagement. We excluded adults who reported they were retired, homemakers, or students, as they are more likely to represent voluntary exits from the workforce. Respondents who responded “don’t know/not sure” or refused to answer the question about testing positive for COVID-19 were excluded from the analyses. In addition, we defined our study population as adults of prime working age (25–54 years); U.S. adults in this age range are most likely to be in the labor force full time or seeking work. 17

COVID-19 and Long COVID history

In 2022, in an emerging core section used to field newly-developed questions, all BRFSS respondents were asked, “Has a doctor, nurse, or other health professional ever told you that you tested positive for COVID-19?” Respondents who said “no” were categorized as “no self-reported COVID-19” Those who answered “yes” or indicated that they had tested positive using a home test without a health professional were considered to have reported having had COVID-19. The respondents classified as having had COVID-19 were then asked, “Did you have any symptoms lasting 3 months or longer that you did not have prior to having coronavirus or COVID-19?” Those who said “no” were categorized as “reported COVID-19, no Long COVID” and those who said yes were categorized as “reported COVID-19 and Long COVID.” For brevity, these three mutually-exclusive groups are referred to henceforth as “no COVID-19”; ”COVID-19, no Long COVID;” and “Long COVID”.

Disability and well-being measures

Every year, the BRFSS core includes questions covering six areas of functional disability: vision, hearing, cognitive (serious difficulty concentrating, remembering, or making decisions due to a physical or mental condition), ambulatory (serious difficulty walking or climbing stairs), self-care (serious difficulty dressing or bathing), and independent living (serious difficulty doing errands alone). We constructed an “any functional disability” measure which was coded as positive for respondents indicating they had at least one specific disability. We also included questions included in BRFSS annually about well-being: general health, physical health, mental health, activity limitations due to poor physical or mental health, and diagnosed depression. Responses to well-being questions involving number of days of the past 30 the respondent reported experiencing activity limitations or reported their physical or mental health was not good were dichotomized; responses of 14 days or greater were coded as experiencing activity limitations, poor physical health, or poor mental health, respectively. All questions, response options, and analytic groupings are found in Supplemental Table 1.

Demographic characteristics and model adjustments

To examine the demographic composition of respondents in each employment status, we assessed weighted prevalences within multiple descriptors: sex (male/female); age in years (25–34, 35–44, 45–54); race/Hispanic ethnicity combined (White Non-Hispanic, Black Non-Hispanic, multi-racial or another Non-Hispanic race, Hispanic); educational attainment (less than high school, high school/GED, some college, and college graduate), and annual household income (<$10,000, $10,000–<$15,000, $15,000–<$20,000, $20,000–<$25,000, $25,000–<$35,000, $35,000–<$50,000, $50,000–<$75,000, and ≥$75,000). We present these distributions as descriptive information but used only a subset of these characteristics for adjustment in subsequent modeling: race/Hispanic ethnicity, sex, and age. We adjusted for these characteristics because they were strongly associated with distribution of COVID-19 cases early in the pandemic (race/Hispanic ethnicity), with severity of COVID-19 illness (age), and with prevalence of Long COVID (sex). The BRFSS program provides imputed values for age and race/Hispanic ethnicity; <2.5% of responses in each category were missing before imputation. Sex and educational attainment were missing for less than 1% of respondents. Income was missing for 19% of respondents in 2022; because we did not adjust for income, we did not impute missing values.

BRFSS ascertains weight and height, as well as a subset of health conditions that have been associated with risk for Long COVID but does not ask about immunosuppression or neurological conditions. Moreover, some of the conditions queried, such as obesity, hypertension, and cardio-cerebrovascular disease, are closely related. Given the complexities of adjusting for chronic conditions in this context, we instead conducted a secondary analysis adjusting for body-mass index based on self-reported height and weight (BMI, categorized here as <25 kg/m2 [underweight or normal weight], 25-<30 kg/m2 [overweight], 30-<40 kg/m2 [obesity], and >=40 kg/m2 [severe obesity]), which is associated with both Long COVID18,19 risk and some of the survey measures of disability20 and well-being. 21,22 BMI was missing for 11% of respondents; we did not impute missing values, so fewer responses were included in the secondary than in the primary analyses.

Statistical analyses

We assessed prevalences of functional disabilities and well-being measures by COVID-19/Long COVID status for each employment category. As a baseline for comparison of the prevalences, we used data from 2019, the last survey year before COVID-19 cases were diagnosed in the U.S.

We calculated distributions of self-reported responses to demographic, disability, and well-being questions for respondents of each included employment status for 2019 and, for 2022, by COVID-19 and Long COVID history. We conducted all analyses using SAS version 9.4 (SAS Institute Inc.) and SAS-callable SUDAAN version 11.0.1 (RTI International, Research Triangle Park) to account for the complex survey design and incorporate respondent sampling weight in BRFSS. The BRFSS program provides data weights based on state demographics distributions. We aggregated the results to obtain national estimates. We used the SURVEYFREQ procedure to estimate population counts and weighted unadjusted prevalences (95% Confidence Intervals [CI]) for all variables. The Rao-Scott chi-square test was used to assess the statistical significance of differences of demographic distributions within each COVID-19/Long COVID status. To assess temporal changes, for each employment status, we compared changes in prevalences of disability and well-being indicators between 2019 and 2022, considering prevalences with non-overlapping 95% CIs statistically significant.

We used the RLOGIST procedure to perform logistic regression to estimate adjusted prevalences in each year-employment status-COVID-19/Long COVID category23 and used the LOGLINK procedure to perform robust Poisson regression24 to generate adjusted prevalence ratios (aPRs) comparing workers of each employment status from each 2022 COVID-19/Long COVID category to the reference group (all workers in that employment status in 2019). We calculated 95% CIs and considered prevalences with non-overlapping 95% CIs and aPRs with 95% CIs not spanning the null statistically significant. These same methods were used for the secondary analysis adjusting for BMI.

RESULTS

Of 418,268 respondents to the 2019 survey, 166,702 were excluded because they were retired, homemakers, students, or did not provide employment status information, leaving 251,566 respondents. Further excluded due to age restrictions were 6,201 respondents aged 18–24 years and 103,981 aged 55 years or older, leaving 136,384 adults of prime working age (25–54 years) in the study population.

In 2022, the survey had 445,132 respondents. Of these, the 9,740 respondents from New Jersey and the U.S. Virgin Islands were excluded because the two locations were not included in the 2019 survey dataset. An additional 173,483 respondents fell under employment status exclusions, leaving 261,909 eligible respondents based on employment status and state of residence. Age exclusions involved 17,511 respondents aged 18–24 years, 94,723 aged 55 years or older, leaving 149,675 adults of prime working age in the study population. In addition, respondents to the 2022 survey who were not asked, responded “don’t know/not sure,” or refused to answer the questions about having had COVID-19 (n=16,279) or Long COVID (n=1,163) were included in the study population but excluded from analyses involving COVID-19 and/or Long COVID, leaving 149,675 respondents in COVID-19 analyses and 52,001 respondents who reported having had COVID-19 and answered “yes” or “no” to the Long COVID question.

Demographics and Body Mass Index

Among respondents to the 2022 survey who met inclusion criteria and had information for the corresponding outcomes, 60.1% reported never having had COVID-19, 30.7% reported having had COVID-19 but not Long COVID, and 9.2% reported having had both COVID-19 and Long COVID. Percentages differed by demographic characteristics and employment status (Table I). Supplemental Table 2 presents results in column display by demographic category and employment status for 2019 and, for 2022, also by COVID-19/Long COVID status.

Table I:

Demographics, body-mass index, and self-reported history of COVID-19 and Long COVID among Behavioral Risk Factor Surveillance System respondents of prime working Age (25–54 years) who were employed, self-employed, unemployed, or unable to work in 2022*

Demographic Item Category Unweighted N Weighted N (thousands)** No reported COVID-19 Weighted % (95% CI)** Reported COVID-19 but not Long COVID Weighted % (95% CI)** Reported COVID-19 and LONG COVID Weighted % (95% CI)**
Total 149,675 108,692 60.1 (59.6, 60.6) 30.7 (30.2, 31.2) 9.2 (8.9, 9.5)
Age*** Age 25 to 34 years 40,622 37,496 58.8 (57.9, 59.7) 32.3 (31.4, 33.1) 8.9 (8.4, 9.4)
Age 35 to 44 years 51,503 37,141 59.5 (58.6, 60.4) 30.8 (30.0, 31.7) 9.7 (9.1, 10.2)
Age 45 to 54 years 57,550 34,055 62.3 (61.4, 63.1) 28.8 (28.0, 29.7) 8.9 (8.4, 9.4)
p-value**** <0.001 <0.001 0.074
Sex*** Male 76,752 57,921 63.3 (62.6, 64.0) 30.1 (29.5, 30.8) 6.6 (6.2, 6.9)
Female 72,923 50,771 56.5 (55.7, 57.3) 31.4 (30.7, 32.1) 12.1 (11.6, 12.7)
p-value**** <0.001 0.011 <0.001
Race/Hispanic Ethnicity*** Non-Hispanic White 101,928 58,860 59.6 (59.0, 60.1) 30.9 (30.4, 31.4) 9.5 (9.2, 9.9)
Non-Hispanic Black 13,359 13,845 62.4 (60.9, 63.9) 29.2 (27.8, 30.6) 8.4 (7.6, 9.3)
Multi-racial and other Non-Hispanic 14,383 13,104 63.7 (61.9, 65.3) 29.1 (27.5, 30.7) 7.3 (6.4, 8.3)
Hispanic 20,005 22,882 58.3 (56.8, 59.7) 32.0 (30.7, 33.4) 9.7 (8.9, 10.6)
p-value**** <0.001 0.004 <0.001
Education*** Below high school 8,143 11,672 68.7 (66.6, 70.7) 23.3 (21.5, 25.2) 8.0 (6.8, 9.3)
High school graduate 31,423 25,858 61.6 (60.5, 62.7) 29.4 (28.3, 30.4) 9.0 (8.4, 9.7)
Some college or technical school 38,130 31,583 57.4 (56.4, 58.4) 31.3 (30.4, 32.3) 11.3 (10.7, 12.0)
College graduate or more 71,432 39,147 58.8 (58.1, 59.5) 33.3 (32.6, 34.0) 7.9 (7.5, 8.3)
p-value**** <0.001 <0.001 <0.001
Household Income*** <$10,000 3,629 3,019 74.6 (71.5, 77.5) 18.0 (15.4, 20.8) 7.4 (5.9, 9.2)
$10,000-$14,999 2,604 1,937 71.9 (67.4, 76.0) 16.9 (14.5, 19.6) 11.2 (7.4, 16.1)
$15,000-$19,999 3,680 3,076 65.7 (62.4, 68.9) 24.4 (21.5, 27.5) 9.9 (8.2, 11.8)
$20,000-$24,999 5,333 4,275 62.7 (59.9, 65.4) 26.5 (24.0, 29.1) 10.8 (9.3, 12.5)
$25,000-$34,999 12,214 9,756 60.8 (59.0, 62.6) 28.6 (26.9, 30.3) 10.6 (9.6, 11.7)
$35,000-$49,999 13,999 10,408 59.9 (58.3, 61.6) 30.0 (28.5, 31.5) 10.1 (9.1, 11.1)
$50,000-$74,999 20,152 13,847 57.6 (56.2, 59.0) 32.0 (30.7, 33.3) 10.4 (9.6, 11.3)
>=$75,000 66,101 44,413 56.9 (56.1, 57.7) 34.5 (33.8, 35.3) 8.6 (8.1, 9.0)
p-value**** <0.001 <0.001 <0.001
Body-mass index category*** Underweight/normal weight (<25 kg/m2) 38,246 27,882,000 63.8 (62.8, 64.7) 29.1 (28.2, 30.1) 7.1 (6.6, 7.6)
Overweight (25-<30 kg/m2) 46,240 33,036,000 60.3 (59.4, 61.2) 31.3 (30.5, 32.2) 8.3 (7.8, 8.8)
Obesity (30-<40 kg/m2) 39,844 28,482,000 56.9 (55.9, 57.9) 32.3 (31.3, 33.2) 10.8 (10.2, 11.4)
Severe obesity (>=40 kg/m2) 10,119 6,950,000 54.2 (52.2, 56.1) 30.1 (28.4, 31.8) 15.7 (14.1, 17.5)
p-value**** <0.001 <0.001 <0.001
Employment Status Employed for wages 113,405 79,941 57.5 (56.9, 58.1) 33.3 (32.7, 33.8) 9.2 (8.8, 9.5)
Self-employed 18,268 14,347 66.4 (65.0, 67.8) 25.2 (23.9, 26.5) 8.4 (7.6, 9.3)
Out of work for <1 year 4,526 3,876 65.9 (63.2, 68.6) 23.7 (21.4, 26.2) 10.3 (8.8, 12.0)
Out of work for 1+ year 4,367 3,723 69.7 (66.8, 72.5) 22.8 (20.2, 25.5) 7.5 (6.1, 9.2)
Unable to work 9,109 6,805 68.8 (66.8, 70.8) 20.4 (18.7, 22.3) 10.8 (9.6, 12.1)
p-value**** <0.001 <0.001 0.003
*

New Jersey and U.S. Virgin Islands excluded from all analyses because they were not included in 2019 dataset

**

Weighted, unadjusted prevalences.

***

Income was missing for 19% of respondents in 2022. BRFSS provides imputed values for age and race/Hispanic ethnicity; <2.5% of responses in each category were missing before imputation. Sex and educational attainment were missing for fewer than 1% of respondents. BMI was missing for 11% of respondents.

****

Rao-Scott chi-square test for prevalence difference among demographic categories within each column

While respondents aged 25–34 years had the highest prevalence of having a history of COVID-19 without experiencing Long COVID (32.3%), the highest prevalence of Long COVID was among those aged 35–44 years (9.7%), although differences between age groups were not statistically significant (Table I). In contrast, despite having only a slightly higher prevalence than men of having had COVID-19 without experiencing Long COVID, women were 83% more likely to report Long COVID (12.1% vs. 6.6%). Hispanic respondents had the highest prevalences of both COVID-19 without Long COVID and Long COVID, but confidence intervals overlapped for most race/Hispanic ethnicity categories. Respondents who had college degrees had the highest prevalence, and those who had not completed high school the lowest prevalence, of reported COVID-19. However, respondents with some college or technical school had the highest prevalence and those who had completed college the lowest prevalence of reported Long COVID.

Respondents employed for wages had the highest prevalence of a history of COVID-19 without experiencing Long COVID (33.3%) and those unable to work had the lowest prevalence of this history (20.4%). In contrast, those unable to work had the highest prevalence of reported Long COVID (10.8%), followed by those out of work less than a year (10.3%) and workers employed for wages (9.2%), the self-employed (8.4%), and those out of work more than a year (7.5%).

Among all included respondents, prevalence of obesity and severe obesity combined increased from 34.0% in 2019 to 36.8% in 2022 (data not shown). Compared to 2019 comparison levels, obesity and severe obesity had a non-significant increase in the no COVID-19 group, a somewhat larger, statistically significant increase in the COVID-19, no Long COVID group, and the largest increase among those experiencing Long COVID. Obesity (including severe obesity) was observed in 47.2% and severe obesity in 12.4% of those experiencing Long COVID (with the latter comprising double the 6.2% prevalence of severe obesity observed at the 2019 baseline, data not shown).

Prevalences of functional disabilities and well-being overall and by employment status, 2019 and 2022

Between 2019 and 2022, the prevalence of any functional disability in the study population increased from 21.0% to 22.7%; the increase was statistically significant (Table II). Along with any disability, vision, cognitive, and independent living disabilities had statistically significant increases during this time, and the increase for hearing disability approached statistical significance. Increases in several well-being measures – depression, poor mental health, and activity limitations – were also statistically significant. In contrast, two types of disability, self-care and ambulatory, and one well-being measure, fair/poor general health, had statistically significant decreases for the full study population between 2019 and 2022.

Table II:

Unadjusted prevalences of functional disability and well-being measures 2019 vs. 2022 by employment status** among Behavioral Risk Factor Surveillance System Respondents Ages 25–54 years

Disability or well-being measure Employment status 2019 Unadjusted prevalence (95% CI) 2022 Unadjusted prevalence (95% CI)
Any functional disability*** All below 21.0 (20.6, 21.5) 22.7 (22.3, 23.1)
Employed for wages 14.5 (14.0, 14.9) 16.8 (16.4, 17.3)
Self-employed 17.3 (16.2, 18.5) 19.8 (18.6, 21.1)
Out of work for <1 year 32.6 (30.1, 35.1) 35.8 (33.1, 38.5)
Out of work for 1+ year 44.2 (41.3, 47.1) 44.9 (42.0, 47.7)
Unable to work 82.3 (80.9, 83.7) 77.7 (75.7, 79.6)
Hearing All below 3.3 (3.1, 3.5) 3.5 (3.4, 3.7)
Employed for wages 2.5 (2.3, 2.7) 2.8 (2.6, 2.9)
Self-employed 3.5 (2.9, 4.2) 3.6 (3.1, 4.2)
Out of work for <1 year 3.8 (3.0, 4.7) 4.3 (3.2, 5.5)
Out of work for 1+ year 5.2 (4.0, 6.7) 6.1 (4.8, 7.6)
Unable to work 10.2 (9.3, 11.3) 10.7 (9.4, 12.0)
Vision All below 4.1 (3.9, 4.3) 4.5 (4.3, 4.8)
Employed for wages 2.7 (2.5, 2.9) 2.9 (2.7, 3.1)
Self-employed 3.1 (2.7, 3.6) 4.2 (3.5, 4.9)
Out of work for <1 year 5.7 (4.5, 7.1) 6.4 (5.4, 7.7)
Out of work for 1+ year 10.1 (8.5, 12.0) 10.6 (8.9, 12.5)
Unable to work 17.6 (16.3, 18.9) 20.0 (18.3, 21.8)
Cognitive All below 11.8 (11.5, 12.1) 13.3 (13.0, 13.7)
Employed for wages 7.5 (7.2, 7.8) 9.6 (9.2, 9.9)
Self-employed 9.1 (8.3, 9.9) 11.1 (10.2, 12.1)
Out of work for <1 year 21.4 (19.2, 23.6) 23.9 (21.6, 26.3)
Out of work for 1+ year 27.5 (25.0, 30.2) 29.1 (26.5, 31.8)
Unable to work 51.2 (49.4, 53.0) 47.5 (45.4, 49.5)
Ambulatory (difficulty walking or climbing stairs) All below 8.5 (8.3, 8.8) 7.7 (7.5, 8.0)
Employed for wages 4.1 (3.8, 4.3) 4.0 (3.7, 4.2)
Self-employed 5.0 (4.4, 5.8) 5.5 (4.8, 6.3)
Out of work for <1 year 10.5 (9.1, 12.1) 10.0 (8.5, 11.8)
Out of work for 1+ year 18.3 (16.3, 20.3) 16.5 (14.5, 18.7)
Unable to work 57.6 (55.9, 59.4) 50.4 (48.3, 52.5)
Self-care (dressing or bathing) All below 3.1 (3.0, 3.3) 2.8 (2.7, 3.0)
Employed for wages 1.0 (0.9, 1.1) 1.0 (0.9, 1.1)
Self-employed 1.3 (1.0, 1.7) 1.7 (1.2, 2.2)
Out of work for <1 year 4.2 (3.1, 5.6) 3.3 (2.4, 4.3)
Out of work for 1+ year 6.3 (5.2, 7.5) 6.3 (5.0, 7.8)
Unable to work 27.7 (26.2, 29.3) 24.7 (22.9, 26.4)
Independent living (difficulty doing errands alone) All below 5.9 (5.7, 6.1) 6.4 (6.1, 6.7)
Employed for wages 2.2 (2.1, 2.4) 3.0 (2.8, 3.2)
Self-employed 3.1 (2.6, 3.7) 4.3 (3.7, 5.0)
Out of work for <1 year 8.3 (7.0, 9.7) 9.8 (8.3, 11.5)
Out of work for 1+ year 16.6 (14.7, 18.7) 17.4 (15.2, 19.8)
Unable to work 44.9 (43.1, 46.7) 42.8 (40.8, 44.9)
Depression All below 19.5 (19.1, 19.8) 22.1 (21.7, 22.4)
Employed for wages 15.8 (15.5, 16.2) 19.5 (19.1, 19.9)
Self-employed 14.7 (13.7, 15.8) 16.5 (15.5, 17.6)
Out of work for <1 year 29.6 (27.3, 32.0) 30.8 (28.4, 33.4)
Out of work for 1+ year 34.8 (32.1, 37.5) 32.5 (29.9, 35.1)
Unable to work 54.9 (53.1, 56.7) 53.4 (51.3, 55.5)
Fair/poor general health All below 15.9 (15.5, 16.2) 14.9 (14.5, 15.2)
Employed for wages 11.3 (10.9, 11.6) 10.9 (10.5, 11.3)
Self-employed 12.3 (11.4, 13.2) 11.4 (10.5, 12.4)
Out of work for <1 year 22.5 (20.3, 24.8) 22.6 (20.3, 24.9)
Out of work for 1+ year 31.2 (28.7, 33.9) 29.5 (27.0, 32.2)
Unable to work 61.6 (59.9, 63.3) 57.1 (55.0, 59.1)
Poor mental health (14+ days of past 30 mental health not good) All below 14.6 (14.3, 15.0) 17.5 (17.1, 17.9)
Employed for wages 11.3 (10.9, 11.7) 14.8 (14.4, 15.2)
Self-employed 11.9 (10.9, 12.9) 13.8 (12.8, 14.9)
Out of work for <1 year 24.7 (22.6, 26.9) 30.7 (28.1, 33.3)
Out of work for 1+ year 28.2 (25.8, 30.7) 28.7 (26.2, 31.2)
Unable to work 44.7 (42.9, 46.4) 43.6 (41.6, 45.6)
Poor physical health (14+ days of past 30 physical health not good) All below 10.3 (10.0, 10.6) 10.5 (10.2, 10.8)
Employed for wages 6.1 (5.8, 6.4) 7.1 (6.7, 7.4)
Self-employed 8.0 (7.2, 8.9) 8.3 (7.5, 9.1)
Out of work for <1 year 15.8 (14.0, 17.7) 16.5 (14.3, 18.8)
Out of work for 1+ year 20.9 (18.8, 23.1) 19.2 (17.1, 21.4)
Unable to work 53.1 (51.4, 54.9) 48.7 (46.6, 50.8)
Activity limitations (14+ days poor physical or mental health preventing usual activities) All below 8.0 (7.8, 8.3) 8.8 (8.6, 9.1)
Employed for wages 3.7 (3.5, 3.9) 5.0 (4.8, 5.2)
Self-employed 5.5 (4.8, 6.3) 6.6 (5.9, 7.4)
Out of work for <1 year 16.0 (14.2, 17.9) 20.4 (18.2, 22.7)
Out of work for 1+ year 22.2 (20.0, 24.5) 22.6 (20.3, 25.2)
Unable to work 49.9 (48.1, 51.7) 45.8 (43.8, 47.9)

Italics indicate statistically significant differences between 2019 and 2022 for an outcome-employment status combination based on prevalences with non-overlapping 95% CIs.

*

New Jersey and U.S. Virgin Islands excluded from all analyses because they were not included in 2019 dataset

**

Excludes respondents self-reporting employment status as retired, homemaker, or student

***

Any of the six functional disabilities ascertained by BRFSS.

Across most disabilities and adverse well-being measures, statistically significant increases between 2019 and 2022 were most frequently observed among those employed for wages, the self-employed, and the short-term unemployed (Table II). In 2022, the prevalence of any disability was 16.8% among those employed for wages and 19.8% among the self-employed. Among these groups, the most common disability was cognitive, reported by 9.6% of employed and 11.1% of self-employed respondents in 2022 (compared to 7.5% and 9.1%, respectively, in 2019). Changes in prevalence for most measures were smaller and not statistically significant among the long-term unemployed. In contrast to the employed and self-employed, those unable to work had decreases for most measures, with some changes statistically significant.

While temporal increases in the prevalence of disability and adverse well-being were more pronounced among workers, within each year the prevalence of every outcome increased through the continuum from the employed/self-employed to the unemployed to those unable to work (Table II). In both years, prevalences of every disability, along with the well-being measures poor general health, poor physical health, and activity limitations were higher among the self-employed than among those employed for wages, although some confidence intervals overlapped. In contrast, the prevalence of depression was higher among those employed for wages, with the prevalence difference between the two employment types increasing from 1.1% in 2019 to 3.0% in 2022, reflecting primarily the 3.7% increase in depression among the employed. In 2022, the prevalence of poor mental health was also higher among those employed for wages. The prevalence of almost every adverse well-being outcome was higher among the long-term unemployed than among the short-term unemployed in both years. For most outcomes, differences in prevalences between the short and long-term unemployed decreased between 2019 and 2022.

Disability by year, employment status, and self-reported COVID-19 and Long COVID history

Among those with Long COVID, one in four respondents employed for wages and nearly one third of the self-employed reported at least one functional disability (Table III). Among employed and self-employed workers, aPRs for every functional disability had statistically significant elevations comparing 2022 respondents with Long COVID to respondents in the same employment status in 2019 (Table III). The aPRs exceeded 2.0 for hearing, vision, and self-care disabilities among the self-employed and for cognitive and independent living disabilities among both the employed and self-employed with Long COVID compared to employed and self-employed respondents, respectively, in 2019.

Table III:

Functional disabilities among Behavioral Risk Factor Surveillance System* respondents ages 25–54 years by employment status and self-reported COVID-19 and Long COVID: 2022 prevalences and adjusted prevalence ratios (aPRs) compared to 2019 respondents in same employment category

2019 2022
Unadjusted prevalence (95% CI)**
Adjusted prevalence (95% CI) ***
Unadjusted prevalence (95% CI)**
aPR (95% CI) compared to 2019***
Outcome Employment status No COVID-19 COVID-19, no Long COVID COVID-19 and Long COVID
Any functional disability Employed for wages 14.5 (14.0, 14.9)
14.5 (14.1, 14.9)
16.1 (15.5, 16.7)
1.12 (1.07, 1.17)
15.2 (14.5, 16.0)
1.05 (0.99, 1.12)
25.7 (24.0, 27.5)
1.75 (1.63, 1.88)
Self-employed 17.3 (16.2, 18.5)
17.5 (16.4, 18.6)
19.7 (18.1, 21.5)
1.14 (1.03, 1.27)
15.6 (13.7, 17.6)
0.90 (0.78, 1.03)
31.3 (26.3, 36.7)
1.78 (1.49, 2.12)
Out of work for <1 year 32.6 (30.1, 35.1)
32.2 (29.8, 34.7)
33.7 (30.3, 37.3)
1.05 (0.92, 1.19)
35.5 (30.1, 41.2)
1.07 (0.91, 1.27)
50.2 (42.1, 58.2)
1.51 (1.27, 1.80)
Out of work for 1+ year 44.2 (41.3, 47.1)
43.6 (40.8, 46.5)
44.0 (40.5, 47.6)
1.01 (0.92, 1.12)
41.5 (34.8, 48.3)
0.92 (0.77, 1.09)
53.1 (42.4, 63.6)
1.17 (0.95, 1.45)
Unable to work 82.3 (80.9, 83.7)
82.0 (80.6, 83.4)
77.2 (74.7, 79.5)
0.93 (0.91, 0.98)
77.8 (73.2, 82.0)
0.94 (0.88, 0.99)
87.7 (82.7, 91.6)
1.05 (1.00, 1.11)
Hearing Employed for wages 2.5 (2.3, 2.7)
2.5 (2.4, 2.7)
2.6 (2.4, 2.8)
1.02 (0.92, 1.14)
2.5 (2.2, 2.8)
1.00 (0.88, 1.14)
4.2 (3.4, 5.2)
1.84 (1.47, 2.30)
Self-employed 3.5 (2.9, 4.2)
3.3 (2.7, 3.9)
3.4 (2.8, 4.1)
0.97 (0.76, 1.24)
2.4 (1.7, 3.3)
0.70 (0.49, 1.01)
7.3 (3.7, 12.6)
2.28 (1.29, 4.03)
Out of work for <1 year 3.8 (3.0, 4.7)
4.0 (3.3, 5.0)
4.5 (3.1, 6.3)
1.20 (0.80, 1.79)
3.4 (1.8, 5.7)
0.90 (0.51, 1.60)
****
1.45 (0.72, 2.92)
Out of work for 1+ year 5.2 (4.0, 6.7)
5.5 (4.3, 7.1)
6.5 (4.9, 8.6)
1.22 (0.85, 1.77)
4.1 (2.1, 7.1)
0.82 (0.44, 1.54)
****
0.93 (0.38. 2.28)
Unable to work 10.2 (9.3, 11.3)
10.1 (9.2, 11.2)
10.4 (9.0, 11.9)
1.00 (0.85, 1.19)
10.7 (7.0, 15.5)
1.10 (0.75, 1.61)
14.5 (10.5, 19.4)
1.52 (1.12, 2.07)
Vision Employed for wages 2.7 (2.5, 2.9)
2.7 (2.5, 3.0)
2.9 (2.6, 3.2)
1.07 (0.95, 1.21)
2.7 (2.3, 3.2)
1.02 (0.87, 1.20)
3.6 (3.0, 4.2)
1.29 (1.08, 1.54)
Self-employed 3.1 (2.7, 3.6)
3.2 (2.8, 3.6)
4.0 (3.2, 5.0)
1.27 (0.99, 1.63)
3.0 (2.1, 4.2)
0.94 (0.66, 1.33)
8.8 (5.3, 13.5)
2.65 (1.67, 4.21)
Out of work for <1 year 5.7 (4.5, 7.1)
5.4 (4.3, 6.7)
5.9 (4.6, 7.6)
1.06 (0.77, 1.48)
5.5 (3.8, 7.7)
0.94 (0.63, 1.40)
10.3 (6.5, 15.3)
1.67 (1.05, 2.66)
Out of work for 1+ year 10.1 (8.5, 12.0)
9.2 (7.7, 10.9)
12.1 (9.7, 14.8)
1.24 (0.95, 1.62)
6.1 (3.6, 9.5)
0.55 (0.33, 0.89)
11.7 (7.0, 18.0)
1.06 (0.65, 1.72)
Unable to work 17.6 (16.3, 18.9)
16.0 (14.8, 17.3)
19.2 (17.1, 21.4)
1.09 (0.95, 1.24)
22.7 (18.1, 27.7)
1.22 (0.99, 1.51)
20.7 (16.5, 25.4)
1.20 (0.96, 1.51)
Cognitive Employed for wages 7.5 (7.2, 7.8)
7.4 (7.1, 7.7)
9.1 (8.7, 9.6)
1.23 (1.15, 1.31)
8.7 (8.1, 9.3)
1.15 (1.06, 1.24)
16.4 (15.1, 17.7)
2.12 (1.94, 2.31)
Self-employed 9.1 (8.3, 9.9)
9.5 (8.7, 10.4)
10.7 (9.5, 12.1)
1.18 (1.02, 1.37)
9.0 (7.6, 10.6)
0.98 (0.82, 1.18)
21.4 (17.2, 26.0)
2.27 (1.82, 2.83)
Out of work for <1 year 21.4 (19.2, 23.6)
20.7 (18.7, 22.9)
22.4 (19.6, 25.5)
1.06 (0.90, 1.25)
24.6 (19.6, 30.2)
1.12 (0.89, 1.41)
34.6 (27.5, 42.2)
1.59 (1.27, 2.00)
Out of work for 1+ year 27.5 (25.0, 30.2)
27.5 (24.9, 30.2)
28.3 (25.0, 31.8)
1.04 (0.90, 1.21)
27.4 (21.7, 33.7)
0.97 (0.78, 1.22)
41.0 (31.2, 51.3)
1.47 (1.11, 1.94)
Unable to work 51.2 (49.4, 53.0)
53.3 (51.5, 55.1)
47.0 (44.4, 49.6)
0.92 (0.86, 0.98)
44.4 (39.6, 49.4)
0.85 (0.76, 0.94)
60.8 (54.7, 66.6)
1.14 (1.03, 1.26)
Ambulatory (walking or climbing stairs) Employed for wages 4.1 (3.8, 4.3)
4.2 (3.9, 4.4)
3.9 (3.6, 4.2)
0.96 (0.87, 1.05)
3.3 (2.9, 3.8)
0.83 (0.72, 0.95)
6.8 (6.0, 7.7)
1.63 (1.42, 1.86)
Self-employed 5.0 (4.4, 5.8)
4.9 (4.3, 5.6)
5.6 (4.6, 6.7)
1.12 (0.89, 1.41)
4.4 (3.3, 5.7)
0.87 (0.65, 1.18)
9.4 (6.6, 13.0)
1.86 (1.32, 2.62)
Out of work for <1 year 10.5 (9.1, 12.1)
11.0 (9.6, 12.6)
8.1 (6.4, 10.1)
0.80 (0.62, 1.04)
10.2 (6.9, 14.4)
0.98 (0.67, 1.44)
17.7 (11.8, 24.9)
1.60 (1.12, 2.29)
Out of work for 1+ year 18.3 (16.3, 20.3)
17.4 (15.6, 19.4)
16.6 (14.1, 19.4)
0.95 (0.79, 1.14)
14.9 (10.5, 20.1)
0.81 (0.58, 1.12)
22.9 (14.9, 32.6)
1.15 (0.80, 1.64)
Unable to work 57.6 (55.9, 59.4)
51.9 (50.1, 53.8)
49.6 (47.0, 52.2)
0.89 (0.84, 0.94)
50.9 (45.9, 55.8)
0.90 (0.80, 1.01)
58.3 (52.1, 64.3)
0.99 (0.90, 1.10)
Self-care (dressing or bathing) Employed for wages 1.0 (0.9, 1.1)
1.0 (0.9, 1.1)
1.0 (0.8, 1.2)
1.00 (0.81, 1.24)
0.8 (0.6, 1.0)
0.84 (0.66, 1.08)
1.8 (1.4, 2.3)
1.88 (1.44, 2.46)
Self-employed 1.3 (1.0, 1.7)
1.3 (1.0, 1.6)
1.6 (1.0, 2.4)
1.24 (0.76, 2.02)
1.0 (0.6, 1.6)
0.76 (0.45, 1.29)
****
2.63 (1.28, 5.40)
Out of work for <1 year 4.2 (3.1, 5.6)
4.4 (3.3, 5.8)
2.6 (1.6, 3.9)
0.62 (0.37, 1.02)
3.1 (1.6, 5.5)
0.75 (0.40, 1.42)
****
1.36 (0.71, 2.60)
Out of work for 1+ year 6.3 (5.2, 7.5)
6.2 (5.2, 7.3)
6.1 (4.5, 8.0)
0.98 (0.71, 1.36)
4.8 (2.5, 8.3)
0.76 (0.42, 1.36)
****
1.97 (1.04, 3.72)
Unable to work 27.7 (26.2, 29.3)
25.5 (24.0, 27.1)
23.5 (21.6, 25.6)
0.85 (0.77, 0.94)
24.0 (19.3, 29.2)
0.88 (0.71, 1.09)
31.0 (25.5, 36.9)
1.13 (0.94, 1.36)
Independent living (doing errands alone) Employed for wages 2.2 (2.1, 2.4)
2.2 (2.0, 2.4)
2.9 (2.6, 3.1)
1.30 (1.16, 1.46)
2.6 (2.2, 3.0)
1.16 (1.00, 1.36)
5.7 (4.6, 7.0)
2.47 (1.99, 3.07)
Self-employed 3.1 (2.6, 3.7)
3.3 (2.8, 3.8)
4.4 (3.5, 5.4)
1.40 (1.08, 1.82)
3.1 (2.2, 4.1)
0.98 (0.70, 1.37)
8.4 (5.5, 12.1)
2.57 (1.71, 3.86)
Out of work for <1 year 8.3 (7.0, 9.7)
8.3 (7.0, 9.7)
10.0 (8.0, 12.2)
1.23 (0.95, 1.59)
8.8 (5.9, 12.5)
1.04 (0.71, 1.54)
12.2 (8.1, 17.4)
1.43 (0.97, 2.13)
Out of work for 1+ year 16.6 (14.7, 18.7)
16.6 (14.7, 18.7)
16.7 (13.9, 19.9)
1.03 (0.84, 1.27)
16.3 (12.0, 21.4)
0.98 (0.72, 1.32)
23.3 (15.2, 33.2)
1.34 (0.90, 2.01)
Unable to work 44.9 (43.1, 46.7)
45.4 (43.6, 47.2)
41.8 (39.3, 44.4)
0.95 (0.88, 1.02)
42.3 (37.3, 47.4)
0.94 (0.83, 1.07)
55.3 (49.1, 61.4)
1.16 (1.03, 1.30)

aPR = adjusted prevalence ratio

Italicization indicates aPR elevation or deficit comparing adjusted prevalence in 2022 category to 2019 baseline is statistically significant based on aPRs with 95% CIs not spanning the null.

*

New Jersey and U.S. Virgin Islands excluded from all analyses because they were not included in 2019 dataset

**

Weighted

***

Weighted and adjusted for age in years (25–34, 35–44, 45–54), sex (male/female), and race/Hispanic ethnicity (White Non-Hispanic, Black Non-Hispanic, multi-racial or another Non-Hispanic race, Hispanic)

****

Not reportable, Relative Standard Error (RSE) > 30%

Cognitive disability had the highest prevalence of any functional disability for both years, in every employment category except unable to work, and, in 2022, every COVID-19/Long COVID status (Table III). In 2019, the prevalence of cognitive disability was 7.5% among the employed and 9.1% among the self-employed. In 2022, prevalences of cognitive disability among the employed were 9.1% (no COVID-19), 8.7% (COVID-19, no Long COVID), and 16.4% (Long COVID); among the self-employed, corresponding prevalences were 10.7%, 9.0%, and 21.4%. Prevalences of cognitive disability increased with duration of unemployment and were highest among those unable to work, reaching a prevalence of 60.8% among those who reported a history of Long COVID in 2022

Among the Long COVID group, the prevalence of every statistically reportable disability was higher among those who were not working (short-term unemployed, long-term unemployed, unable to work) in 2022 than among the employed and self-employed (Table III). However, for many disabilities, the relative increases in prevalence, as measured by aPRs comparing those reporting Long COVID by 2022 to those in the same employment status in 2019, were larger among workers. Still, aPRs for multiple disabilities were significantly elevated among the unemployed, as well as those who were unable to work, who reported Long COVID.

Among respondents who did not report Long COVID (regardless of COVID-19 history), most aPRs comparing 2022 to 2019 prevalences by employment status did not have statistically significant elevations (Table III). Exceptions include cognitive disability, which was significantly elevated among the employed regardless of COVID-19 history, as well as independent living, which was significantly elevated among the employed and self-employed who had not had COVID-19. The aPR for ambulatory disability had a statistically significant deficit among employed workers with a history of COVID-19 but not Long COVID.

After additional adjustment for BMI (Supplemental Table 3), aPRs described above decreased somewhat without, for most employment and COVID/Long COVID status groups, leading to changes in direction or statistical significance. However, among those unable to work, elevated aPRs lost statistical significance or aPR deficits became statistically significant for a number of disabilities.

Well-being measures by year and COVID-19/Long COVID history

In 2022, prevalence estimates for every adverse well-being measure were higher among respondents who self-reported Long COVID than among the no COVID and COVID, no Long COVID groups, regardless of employment status (Table IV). Adjusted PRs comparing prevalences among respondents reporting Long COVID to the 2019 baseline had statistically significant elevations across all outcomes for each employment group except, for some measures, the long-term unemployed. Depression was the most common adverse well-being measure among those reporting Long COVID. While in 2019 depression was reported by 15.8% of employed respondents and 14.7% of self-employed respondents, the 2022 prevalences among workers who reporting Long COVID were approximately double the pre-pandemic levels, at 31.2% and 30.4%, respectively. In addition, nearly one-quarter of employed and more than one fifth of the self-employed reporting Long COVID also reported their mental health was poor for at least 14 of the past 30 days. Poor physical health in the past month was reported by 13.6% of the employed and 16.0% of the self-employed who reported Long COVID, and activity limitations were reported by 8.4% and 12.3% of these groups, respectively. Among those reporting Long COVID, the aPRs exceeded 2.0 for poor mental health among the employed, for poor physical health among the employed (and approached 2.0 among the self-employed), and for activity limitations among the employed and the self-employed.

Table IV:

Measures of well-being among Behavioral Risk Factor Surveillance System respondents* ages 25–54 years by employment status and self-reported COVID-19 and Post-COVID Conditions (Long COVID): 2022 prevalences and adjusted prevalence ratios (aPRs) compared to 2019 respondents in same employment category

2019 2022
Unadjusted prevalence (95% CI)**
Adjusted prevalence (95% CI)***
Unadjusted prevalence (95% CI)**
aPR (95% CI) compared to 2019***
Outcome Employment status No COVID-19 COVID-19, no Long COVID COVID-19 and Long COVID
Depression Employed for wages 15.8 (15.5, 16.2)
15.6 (15.2, 15.9)
18.7 (18.1, 19.3)
1.20 (1.16, 1.25)
19.3 (18.6, 20.1)
1.21 (1.16, 1.27)
31.2 (29.5, 33.0)
1.82 (1.71, 1.93)
Self-employed 14.7 (13.7, 15.8)
15.8 (14.8, 16.9)
15.5 (14.2, 16.9)
1.07 (0.96, 1.20)
17.3 (15.3, 19.5)
1.18 (1.03, 1.35)
30.4 (25.9, 35.2)
1.90 (1.62, 2.24)
Out of work for <1 year 29.6 (27.3, 32.0)
29.8 (27.6, 32.1)
30.1 (26.8, 33.6)
1.06 (0.93, 1.21)
31.7 (26.6, 37.1)
1.05 (0.88, 1.26)
38.7 (31.3, 46.5)
1.25 (1.04, 1.51)
Out of work for 1+ year 34.8 (32.1, 37.5)
35.0 (32.4, 37.8)
31.6 (28.4, 34.9)
0.95 (0.84, 1.07)
34.6 (28.3, 41.3)
1.01 (0.83, 1.23)
46.1 (35.9, 56.5)
1.21 (0.93, 1.58)
Unable to work 54.9 (53.1, 56.7)
55.1 (53.4, 56.9)
53.2 (50.6, 55.9)
1.01 (0.95, 1.07)
51.4 (46.4, 56.4)
0.95 (0.86, 1.05)
67.1 (61.0, 72.7)
1.09 (1.00, 1.20)
Fair/poor general health Employed for wages 11.3 (10.9, 11.6)
11.4 (11.0, 11.8)
10.1 (9.6, 10.7)
0.90 (0.85, 0.96)
10.3 (9.6, 11.1)
0.92 (0.85, 0.99)
17.3 (15.7, 19.0)
1.52 (1.38, 1.68)
Self-employed 12.3 (11.4, 13.2)
12.0 (11.1, 12.9)
11.2 (9.9, 12.5)
0.91 (0.80, 1.04)
9.5 (7.9, 11.3)
0.76 (0.63, 0.92)
18.8 (15.1, 23.0)
1.51 (1.22, 1.86)
Out of work for <1 year 22.5 (20.3, 24.8)
22.2 (20.1, 24.5)
20.4 (17.5, 23.5)
0.91 (0.76, 1.09)
21.6 (17.1, 26.7)
0.93 (0.74, 1.18)
37.3 (29.8, 45.3)
1.61 (1.27, 2.04)
Out of work for 1+ year 31.2 (28.7, 33.9)
30.1 (27.7, 32.7)
30.6 (27.3, 34.0)
1.00 (0.87, 1.14)
27.0 (20.8, 34.0)
0.80 (0.63, 1.02)
35.5 (26.4, 45.5)
1.11 (0.86, 1.43)
Unable to work 61.6 (59.9, 63.3)
60.2 (58.4, 61.9)
54.5 (51.9, 57.2)
0.87 (0.82, 0.93)
56.4 (51.4, 61.3)
0.88 (0.80, 0.96)
74.1 (68.2, 79.4)
1.20 (1.11, 1.30)
Poor mental health (14+ days of past 30 mental health not good) Employed for wages 11.3 (10.9, 11.7)
11.2 (10.8, 11.5)
14.0 (13.5, 14.5)
1.25 (1.19, 1.32)
14.1 (13.4, 14.9)
1.24 (1.17, 1.32)
24.7 (23.0, 26.4)
2.10 (1.95, 2.26)
Self-employed 11.9 (10.9, 12.9)
12.6 (11.6, 13.7)
13.0 (11.8, 14.3)
1.10 (0.97, 1.24)
12.6 (10.7, 14.6)
1.06 (0.89, 1.25)
21.1 (17.4, 25.3)
1.68 (1.38, 2.05)
Out of work for <1 year 24.7 (22.6, 26.9)
24.1 (22.1, 26.3)
31.3 (27.9, 35.0)
1.28 (1.12, 1.47)
28.7 (23.5, 34.3)
1.15 (0.93, 1.41)
35.2 (28.1, 42.8)
1.39 (1.12, 1.73)
Out of work for 1+ year 28.2 (25.8, 30.7)
28.1 (25.7, 30.6)
28.4 (25.3, 31.7)
1.02 (0.89, 1.18)
27.8 (22.1, 34.0)
0.99 (0.80, 1.24)
44.4 (34.2, 54.9)
1.51 (1.16, 1.96)
Unable to work 44.7 (42.9, 46.4)
45.9 (44.1, 47.7)
42.7 (40.1, 45.4)
0.97 (0.90, 1.05)
42.1 (37.4, 46.9)
0.94 (0.83, 1.06)
60.4 (54.2, 66.3)
1.28 (1.16, 1.42)
Poor physical health (14+ days of past 30 physical health not good) Employed for wages 6.1 (5.8, 6.4)
6.1 (5.9, 6.4)
6.1 (5.7, 6.6)
1.01 (0.93, 1.09)
6.8 (6.2, 7.4)
1.11 (1.01, 1.23)
13.6 (11.9, 15.3)
2.18 (1.91, 2.48)
Self-employed 8.0 (7.2, 8.9)
7.8 (7.1, 8.7)
8.0 (6.9, 9.2)
1.01 (0.85, 1.21)
6.9 (5.8, 8.3)
0.87 (0.71, 1.07)
16.0 (11.9, 21.0)
1.98 (1.49, 2.65)
Out of work for <1 year 15.8 (14.0, 17.7)
16.3 (14.5, 18.3)
16.0 (12.8, 19.6)
1.04 (0.82, 1.32)
15.6 (12.0, 19.7)
0.99 (0.76, 1.28)
26.6 (20.0, 34.1)
1.65 (1.24, 2.19)
Out of work for 1+ year 20.9 (18.8, 23.1)
20.8 (18.8, 23.0)
18.2 (15.6, 21.1)
0.89 (0.75, 1.06)
16.8 (12.2, 22.3)
0.79 (0.58, 1.07)
28.6 (21.1, 37.0)
1.31 (0.98, 1.76)
Unable to work 53.1 (51.4, 54.9)
51.3 (49.5, 53.1)
45.8 (43.1, 48.4)
0.87 (0.82, 0.93)
49.7 (44.6, 54.8)
0.94 (0.85, 1.04)
70.1 (63.9, 75.7)
1.27 (1.17, 1.38)
Activity limitations (14+ days poor physical or mental health preventing usual activities) Employed for wages 3.7 (3.5, 3.9)
3.7 (3.5, 3.9)
4.5 (4.2, 4.9)
1.23 (1.12, 1.35)
4.9 (4.4, 5.3)
1.31 (1.18, 1.46)
8.4 (7.5, 9.4)
2.23 (1.96, 2.53)
Self-employed 5.5 (4.8, 6.3)
5.6 (4.9, 6.4)
6.2 (5.3, 7.2)
1.13 (0.92, 1.38)
5.7 (4.5, 7.2)
1.05 (0.81, 1.37)
12.3 (8.4, 17.1)
2.20 (1.52, 3.17)
Out of work for <1 year 16.0 (14.2, 17.9)
16.1 (14.4, 17.9)
19.5 (16.6, 22.7)
1.24 (1.03, 1.49)
20.5 (16.1, 25.6)
1.28 (0.99, 1.64)
26.6 (20.2, 33.8)
1.64 (1.26, 2.15)
Out of work for 1+ year 22.2 (20.0, 24.5)
22.4 (20.2, 24.7)
22.5 (19.5, 25.7)
1.02 (0.87, 1.21)
19.5 (14.6, 25.1)
0.87 (0.66, 1.16)
33.4 (24.3, 43.6)
1.47 (1.08, 2.00)
Unable to work 49.9 (48.1, 51.7)
50.1 (48.2, 51.9)
44.6 (42.0, 47.2)
0.90 (0.84, 0.97)
45.6 (40.6, 50.6)
0.92 (0.82, 1.02)
65.4 (59.5, 70.9)
1.26 (1.15, 1.38)

aPR = adjusted prevalence ratio

Italicization indicates aPR elevation or deficit comparing adjusted prevalence in 2022 category to 2019 baseline is statistically significant based on aPRs with 95% CIs not spanning the null.

*

New Jersey and U.S. Virgin Islands excluded from all analyses because they were not included in 2019 dataset

**

Weighted

***

Weighted and adjusted for age (25–34, 35–44, 45–54), sex (male/female), and race/Hispanic ethnicity (White Non-Hispanic, Black Non-Hispanic, multi-racial or another Non-Hispanic race, Hispanic)

****

Relative Standard Error (RSE) > 30

Employees and the self-employed who did not report Long COVID experienced prevalences of multiple adverse well-being measures that, while lower than prevalences reported by the Long COVID group, were higher than 2019 baseline prevalences (Table IV). The aPRs for both depression and poor mental health were significantly elevated among employees who did not report Long COVID, regardless of COVID-19 history, and the aPR for depression was significantly elevated among the self-employed in the COVID-19, no Long COVID group. For activity limitation, the aPR was significantly elevated among the employed, but not the self-employed, who did not report Long COVID (regardless of COVID-19 history).

As with disabilities, adjustment for BMI category led to somewhat lower aPRs compared to the 2019 baseline for well-being measures (Supplemental Table 4). In most cases, statistical significance did not change. However, loss of statistical significance (for elevated aPRs) or gain of statistical significance (for aPR deficits) occurred for several well-being measures for specific employment status in specific COVID-19/Long COVID history combinations: among the employed, poor physical health in the Long COVID group; among the short-term unemployed, activity limitations in the no COVID group and depression and poor mental health among those with Long COVID; among the Long-term unemployed, activity limitations in those with Long COVID, and among those unable to work, activity limitations and depression in the COVID-19, no Long COVID group and fair/poor general health among those with Long COVID.

DISCUSSION

The high prevalences of both functional disabilities and adverse well-being among employed and self-employed 2022 BRFSS survey respondents with a history of Long COVID have implications for both workers and employers. Also concerning is the finding of lower but statistically significant increases observed in prevalences of cognitive disability, diagnosed depression, poor mental health, and activity limitations among the larger number of employees (and some self-employed workers) reporting they had not had Long COVID.

Among workers with Long COVID, aPRs comparing 2022 prevalences to the 2019 baseline were significantly elevated for every functional disability and every adverse well-being measure ascertained in BRFSS (although the aPR for self-care was not reportable for the self-employed). Adverse well-being measures related to mental health were high among both employed and self-employed respondents, reinforcing the need for mental health supports across the workforce. The picture for functional disabilities differed somewhat, with higher prevalences of each statistically reportable disability among the self-employed than those employed for wages. While the higher prevalence of disability among the self-employed may indicate greater flexibility to manage disability in the context of self-employment, the finding is nonetheless problematic. The self-employed were significantly less likely than the employed to have health insurance before the pandemic,25 potentially hindering access to the medical and rehabilitation services needed to address these issues. In a U.S. internet survey that did not query employment status, adults currently experiencing Long COVID were more likely than adults not currently experiencing Long COVID or never diagnosed with COVID-19 to not have received needed healthcare in the past year due to cost, along with increased logistical difficulties accessing care.26 Affordable, accessible healthcare will be key to continued employability in workers with Long COVID and to the ability to seek employment among those with Long COVID who are unemployed. In addition, workers with Long COVID may need workplace accommodations, such as remote work and flexible scheduling.27 Consistent with other U.S. surveys,28,29 respondents with Long COVID in this study were more likely to be female or Hispanic; thus, developing treatments for Long COVID, ensuring that people with Long COVID can access healthcare, and addressing resulting workplace accommodation needs are health equity issues.

While 2022 prevalences of functional disability and adverse well-being measures were lower among the employed and self-employed not reporting Long COVID, regardless of history of COVID-19, these workers also had statistically significant increased prevalences compared to 2019 respondents in the same employment categories for multiple disability and well-being measures that might affect workplace performance: cognitive and independent living disabilities, depression, poor mental health and, for the employed, poor physical health. Concerns about healthcare access and workplace accommodations apply to these groups as well.

Cognitive disability was the most common functional disability for employed and self-employed respondents of each COVID-19/Long COVID status. An internet study found that neurocognitive symptoms were associated with reduced likelihood of working full time.30 An assessment of patients in a Long COVID clinic followed for an average of 7 months after acute illness found that 44% had cognitive impairments compared to healthy controls; deficits were particularly pronounced in global cognition, working memory and executive function, and less pronounced but present in verbal fluency, verbal learning, and verbal memory.31 Another study found marked slowing on multiple domains among Long COVID clinic patients; the cognitive slowing was associated with level of depression and appeared to worsen with time since infection.32 In both investigations, cognitive effects were independent of whether the subjects had been hospitalized during the acute phase of illness.31,32 These findings are concerning, given the prevalence of cognitive impairment in our study population in 2022. For employees with Long COVID, this finding is consistent with those of other research.3 The additional finding in our study of increased cognitive disability among workers who had not experienced Long COVID, including those who had not had COVID-19, may reflect under-ascertainment of COVID-19 and Long COVID among respondents, cognitive effects of worsening mental health during this time period,33 or temporal changes in other domains related or unrelated to the pandemic.

Findings of previous research about the prevalence of Long COVID, as well as the impact of Long COVID on employment, vary by when the research was conducted, definitions of Long COVID (ascertainment criteria, including duration and severity of symptoms), study type, study population, and more.3,34 Longitudinal data from the Understanding America Study suggest that as of June 2021, respondents with Long COVID whose condition affected their ability to work were more likely than other respondents to have altered their employment type (employed to self-employed or the converse) and that those with Long COVID had reduced their hours by an average of nearly 10 hours per week.8 Data from a nationally representative cross-sectional survey with a shorter symptom duration threshold (≥4 weeks) found adults of working age with Long COVID were more likely to be out of the labor force due to health or disability than those who had been diagnosed with COVID-19 but did not have Long COVID (11% vs. 5%). In addition, 24% of respondents with Long COVID had limited their activities outside of work in order to keep working.18,27

Strengths of this study are that BRFSS is a nationally representative survey (although NJ and USVI were omitted from these analyses) that collects data from a large number of respondents, with more than 135,000 employed or self-employed respondents in 2019 and nearly 150,000 respondents in 2022 survey meeting inclusion criteria for this study. This large sample facilitates generation of reportable estimates even for many less common disabilities. While early pandemic closures of schools and business may have contributed to some of the adverse mental health findings, by 2022, most of these were again open in person. While the COVID-19 and Long COVID history measures are effectively cumulative in BRFSS, reflecting infections and sequelae from the start of the pandemic in the U.S. to the interview date, responses about disability and all well-being measures except diagnosed depression refer to the interview date. Thus 2022 responses for these items are less likely to reflect acute reactions to job loss and other events that were most common during the first 18 months of the pandemic.

This study has a number of limitations, foremost of which is the cross-sectional nature of the data. Most notably, temporal relationships between COVID-19 illness, the development of Long COVID symptoms, other health changes, and employment status, cannot be determined from this cross-sectional dataset. Data were collected throughout 2022 and timing of infection was not collected; infections leading to Long COVID could be from wild-type SARS-CoV-2 or any variant present through the time of survey completion. Bias must also be considered. Adjustment for BMI category generally led to small decreases in aPRs, with loss of statistical significance for some functional disabilities; these changes concentrated among those with Long COVID who were unable to work. However, height and/or weight was missing for 11% of respondents. Moreover, height and weight, like all data in BRFSS, are self-reported. Self-reported height and weight are subject to bias; a variety of correction factors have been proposed,3538 with some including variables that are outcomes in the current study (e.g., self-rated health). As we did not include a correction factor in the secondary analyses adjusting for BMI category, our findings may underestimate the effects that would have been observed had BMI been calculated using regression-corrected height and weight. Respondents reporting Long COVID had the largest increases in prevalence of obesity and severe obesity compared to 2019 levels, and those reporting Long COVID who were unable to work comprised the employment status group with the highest prevalence of these conditions in both 2019 and 2022. Changes to well-being measures after adjustment for BMI category were not concentrated in a specific COVID-19/Long COVID or employment status category. The finding that aPRs decreased somewhat across employment and COVID-19/Long COVID status after adjustment for BMI category may reflect the general increase in obesity between 2019 and 2022 reported by study respondents or additional risk conferred by elevated BMI for other chronic conditions,39 functional disabilities20 and adverse well-being,21 or Long COVID.18,19 The directionality of these association cannot be assessed in the context of this cross-sectional study. Regardless, prevalences of disability and adverse well-being were elevated among respondents with Long COVID, even after this adjustment.

The trajectory of Long COVID is unclear; while the overall prevalence of symptoms decreases with time and some patients have slowly recovered, others experience remitting/relapsing symptoms and some develop new symptoms and conditions.2,4042 Alongside Long COVID, the consequences of both new SARS-CoV-2 infections and unrelated health issues may appear; while the former has been addressed in at least one longitudinal study,42 both remain understudied. We do not know from the BRFSS data whether Long COVID symptoms are leading directly to disability, although other research has found that significant activity limitations are common, reported by 26.4% of adults experiencing Long COVID in June 2023.43 Similarly, the trajectory of workers through employment status (from employed/self-employed to unable to work, and, for some, re-entry to the workforce), the reasons for this trajectory (changes in Long COVID symptoms, other physical or mental health conditions, or economic conditions) could not be observed. Robust, longitudinal studies are needed to fully understand these trajectories and how to support all workers, particularly those with Long COVID. In addition, large, well-controlled studies designed to identify effective rehabilitation strategies for the multitude of symptoms in general and those that cause workplace limitations specifically are lacking, with existing studies often having limited sample sizes, strategies, endpoints, or follow-up, as well as substantial potential for bias in some cases.4446 Guidance from the American Academy of Physical Medicine and Rehabilitation on Long COVID symptoms and conditions provides updated strategies for addressing these issues.47

Information that could provide additional insight into the severity of Long COVID, as well as the impact of COVID-19 and Long COVID on work, was not collected by the survey. The functional disabilities ascertained in BRFSS are ascertained in each year’s survey and are not specific to COVID-19. Moreover, they are dichotomous and are defined as serious impairment, rather than assessing a range of severity as in instruments developed for Long COVID such as the Post-Covid-19 Functional Scale (PCFS), although the latter does not differentiate types of limitation.48 Questions related to mental health are limited to diagnosed depression, days of poor mental health, and activity limitations due to physical or mental health; anxiety, which has been associated with Long COVID,49 was not assessed, nor was a standardized instrument such as the Patient Health Questionnaire-450 used.

The BRFSS dataset lacks measures for “work ability” and does not differentiate between part-time and full-time employment. Some studies have found that workers with Long COVID are more likely to have reduced their hours, while others have found this to be the case only among those with Long COVID who say their health conditions impact work; 8 the current study could not explore this issue. Thus, while the extent of work limitations among respondents reporting disabilities is critical to understanding the impact on individuals and sustainability of an individual’s return to work, as well as productivity,13 these measures could not be assessed in this study. The possibility that Long COVID exacerbated pre-existing functional disabilities to the point of impacting labor market participation, working hours, or job performance could not be assessed.

Misclassification of COVID-19 and Long COVID histories is also of concern. Underascertainment of COVID-19 history in the BRFSS data is highly likely; while a seroprevalence survey of blood donors aged at least 16 years found that 70.3% had antibodies to SARS-CoV-2 from infection (with or without vaccination) as of June-September 2022,51 self-reported prevalence of ever having had COVID-19 was less than half of that level among all 2022 BRFSS respondents (data not shown) and was 39.9% among participants included in our study. The availability of testing was limited during the early months of the pandemic, so asymptomatic or minimally symptomatic cases, particularly, may not have been screened or identified through medical care or testing, leading to misclassification into the “never had COVID-19” group. Misclassification did not disappear once tests were readily available, as testing might have been more or less likely based on workplace testing requirements, access to testing and other healthcare, cost of testing, and level of concern about COVID-19. Long COVID may have been underreported among respondents who did not realize they had COVID-19 and therefore may not have attributed persistent symptoms to Long COVID. Respondents who had COVID-19 also may have underreported Long COVID. In addition, some respondents would not have accrued 3 months post-infection when completing the survey, although they might be experiencing symptoms that limit daily activities or decrease well-being. Others with mild Long COVID symptoms that have resolved may not recall or have identified the experience as Long COVID. At the same time, some respondents reporting Long COVID may have symptoms that started after they had COVID-19 but are attributable to other health conditions. However, the marked differences in well-being and disability observed between those who did and did not report Long COVID are apparent despite any misclassification. History of COVID-19 vaccinations was only asked in an optional module of the 2022 BRFSS survey and thus was not available for the majority of respondents so could not be accounted for, and no information about treatment during acute COVID-19 illness was collected. Longitudinal studies with data on functional disabilities and well-being metrics from 2019 and continuing ascertainment of these metrics and infection and symptom status after the emergence of SARS-CoV-2 are needed to confirm and further elucidate these findings.

Staying up to date with immunization against SARS-CoV-2 has been shown to reduce the risk of developing Long COVID,52, 53 and administration of approved antivirals soon after infection has been shown in some studies to have a mitigating effect, although the estimated benefit differs by study population and many other variables.2,5355 Efforts to prevent transmission of airborne respiratory viruses can reduce long-term sequelae, as well as the number of acute cases. Continued support, including social and economic support, for layered mitigation strategies such as provision of flexible, non-punitive paid sick leave, ventilation and filtration, and the use of masks and respirators can help to reduce workplace transmission.5658 While an economic analysis is beyond the scope of this research, some costs of these control strategies may be recoverable if they offset increased workplace costs stemming from increased prevalences of adverse mental health outcomes and disabilities among those reporting Long COVID. Some costs of providing adequate sick leave so that workers who are infectious can stay home to reduce workplace transmission and those who are ill can recover adequately may be recouped as well. An analysis of Household Pulse Survey data from Fall 2022-Spring 2023 found increased difficulty with household expenses, being behind on housing payments, and being at risk for eviction or foreclosure among those with Long COVID compared to respondents with a history of COVID-19 but not Long COVID.59 Elevations were particularly pronounced among respondents of lower socioeconomic status and those with functional limitations. These findings point to additional personal and social costs of Long COVID. An analysis of 2022 National Health Interview Survey (NHIS) data noted that respondents with Long COVID were more likely than respondents without Long COVID to defer or not receive needed medical care, therapy, and prescriptions due to cost.60 Other potential economic benefits of reduced transmission may include reduced medical and productivity costs associated with other post-acute sequelae of COVID-19 ranging from newly diagnosed type 2 diabetes61 and dementia62 to increased risk of cardiovascular disease.63 An examination of NHIS data found that people who have Long COVID and cardiovascular disease miss more than twice as many workdays as respondents with cardiovascular disease but not Long COVID. Results were similar among respondents with cancer and diabetes; smaller elevations were observed among those with asthma and COPD. However, the cross-sectional design precluded identification of whether diagnoses of chronic conditions preceded or followed COVID-19 diagnosis.18 These findings further highlight the need to prevent Long COVID and support those already diagnosed.

While research suggests that infection with an omicron SARS-CoV-2 variant may be less likely to lead to Long COVID than infection with wild-type SARS-CoV-2 or previous common variants2,53,64 and that vaccination decreases risk of Long COVID,53 the overall number of Long COVID cases is unlikely to decline in the context of high levels of infections.55 Year-round infections continue, with two or more surges per year apparent from wastewater surveillance.65

Conclusions:

Overall well-being among adults of prime working age was worse and many functional disabilities more prevalent in 2022 compared to 2019, with the most pronounced changes occurring among those reporting a history of Long COVID. These findings highlight the need to improve the well-being of the workforce, regardless of Long COVID history, and the need for more research into the prevention and treatment of Long COVID. In the interim, given the activity limitations and decreased well-being associated with Long COVID observed in this study, critical needs include identification and implementations of tailored workplace accommodations to support current employees and facilitate future employment among jobseekers with Long COVID.

Supplementary Material

supplemental tables

Acknowledgments

Work performed at NIOSH, Cincinnati, OH and CDC, Atlanta, GA.

Footnotes

The authors have no relevant financial or non-financial interests to disclose.

Human subjects review: The BRFSS study protocol was reviewed and approved by institutional Review Board at CDC.

Disclaimer: The findings and conclusions presented in this article are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health and the Centers for Disease Control and Prevention.

REFERENCES

  • 1.Parotto M, Gyöngyösi M, Howe K, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. The Lancet Respiratory Medicine. 2023/08/01/ 2023;11(8):739–754. doi: 10.1016/S2213-2600(23)00239-4 [DOI] [PubMed] [Google Scholar]
  • 2.Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. Mar 2023;21(3):133–146. doi: 10.1038/s41579-022-00846-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sheiner L, Salwati N. How much is long COVID reudicng labor force participation? Not much (so far). Vol. 80. 2022. Hutchins Center Working Paper. 10/27/2022. Accessed 01/15/2024. https://www.brookings.edu/wp-content/uploads/2022/10/WP80-Sheiner-Salwati_10.27.pdf
  • 4.Tak CR. The health impact of long COVID: a cross-sectional examination of health-related quality of life, disability, and health status among individuals with self-reported post-acute sequelae of SARS CoV-2 infection at various points of recovery. J Patient Rep Outcomes. 2023;7(1):31. doi: 10.1186/s41687-023-00572-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vélez-Santamaría R, Fernández-Solana J, Méndez-López F, et al. Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and Long COVID infection. Scientific Reports 2023/11/14 2023;13(1):19907. doi: 10.1038/s41598-023-47218-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bach K New data shows long Covid is keeping as many as 4 million people out of work. 2022. 08/24/2022. Accessed 01/15/2024. https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/#:~:text=This%20report%20uses%20the%20new,work%20due%20to%20long%20Covid.
  • 7.Green CE, Leeds JS, Leeds CM. Occupational effects in patients with post-COVID-19 syndrome. Occup Med (Lond). Dec 9 2023;doi: 10.1093/occmed/kqad118 [DOI] [PubMed] [Google Scholar]
  • 8.Ham DI. Long-haulers and labor market outcomes. Vol. 60. 2022. Working Papers. https://www.minneapolisfed.org/research/institute-working-papers/long-haulers-and-labor-market-outcomes. [Google Scholar]
  • 9.Kwon J, Milne R, Rayner C, et al. Impact of Long COVID on productivity and informal caregiving. Eur J Health Econ. Dec 26 2023;doi: 10.1007/s10198-023-01653-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nielsen K, Yarker J. “It’s a rollercoaster”: the recovery and return to work experiences of workers with long COVID. Work & Stress.1–29. doi: 10.1080/02678373.2023.2286654 [DOI] [Google Scholar]
  • 11.Lunt J, Hemming S, Elander J, Baraniak A, Burton K, Ellington D. Experiences of workers with post-COVID-19 symptoms can signpost suitable workplace accommodations. International Journal of Workplace Health Management. 2022;15(3):359–374. doi: 10.1108/IJWHM-03-2021-0075 [DOI] [Google Scholar]
  • 12.Gallegos M, Morgan ML, Burgos-Videla C, Caycho-Rodríguez T, Martino P, Cervigni M. The impact of long Covid on people’s capacity to work. Annals of Work Exposures and Health. 2023;67(7):801–804. doi: 10.1093/annweh/wxad029 [DOI] [PubMed] [Google Scholar]
  • 13.Kerksieck P, Ballouz T, Haile SR, et al. Post COVID-19 condition, work ability and occupational changes in a population-based cohort. Lancet Reg Health Eur. Jun 23 2023;31:100671. doi: 10.1016/j.lanepe.2023.100671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lemhofer C, Sturm C, Loudovici-Krug D, et al. Quality of life and ability to work of patients with Post-COVID syndrome in relation to the number of existing symptoms and the duration since infection up to 12 months: a cross-sectional study. Qual Life Res. Jul 2023;32(7):1991–2002. doi: 10.1007/s11136-023-03369-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hair NL, Urban C. Association of Severe COVID-19 and Persistent COVID-19 Symptoms With Economic Hardship Among US Families. JAMA Network Open. 2023;6(12):e2347318–e2347318. doi: 10.1001/jamanetworkopen.2023.47318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ne’eman A, Maestas N. How has COVID-19 impacted disability employment? Disabil Health J. Apr 2023;16(2):101429. doi: 10.1016/j.dhjo.2022.101429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.U.S. Bureau of Labor Statistics. Civilian labor force participation rate by age,sex, race, and ethnicity. Table 3.3. 2002, 2012, 2022, and projected 2032. Accessed 04/05/2024, https://www.bls.gov/emp/tables/civilian-labor-force-participation-rate.htm
  • 18.Bonner C, Ghouralal S-L. Long COVID and Chronic Conditions in the US Workforce: Prevalence, Productivity Loss, and Disability. Journal of Occupational and Environmental Medicine. 2024;66(3) [DOI] [PubMed] [Google Scholar]
  • 19.Jeffrey K, Woolford L, Maini R, et al. Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study. eClinicalMedicine. 2024/05/01/ 2024;71:102590. doi: 10.1016/j.eclinm.2024.102590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bell JA, Sabia S, Singh-Manoux A, Hamer M, Kivimäki M. Healthy obesity and risk of accelerated functional decline and disability. International Journal of Obesity. 2017/06/01 2017;41(6):866–872. doi: 10.1038/ijo.2017.51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sirtori A, Brunani A, Villa V, et al. Obesity Is a Marker of Reduction in QoL and Disability. The Scientific World Journal. 2012/03/12 2012;2012:167520. doi: 10.1100/2012/167520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ul-Haq Z, Mackay DF, Fenwick E, Pell JP. Meta-analysis of the association between body mass index and health-related quality of life among adults, assessed by the SF-36. Obesity. 2013;21(3):E322–E327. doi: 10.1002/oby.20107 [DOI] [PubMed] [Google Scholar]
  • 23.Korn EL, Graubard BI. Predictive Margins for Survey Data. Biometrics. 1999;55:652–659. [DOI] [PubMed] [Google Scholar]
  • 24.Zou G A Modified Poisson Regression Approach to Prospective Studies with Binary Data. American Journal of Epidemiology. 2004;159(7):702–706. doi: 10.1093/aje/kwh090 [DOI] [PubMed] [Google Scholar]
  • 25.Silver SR, Li J, Quay B. Employment status, unemployment duration, and health-related metrics among US adults of prime working age: Behavioral Risk Factor Surveillance System, 2018–2019. Am J Ind Med. Jan 2022;65(1):59–71. doi: 10.1002/ajim.23308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Karpman M, Zuckerman S, Morriss S. Health Care Access and Affordability Among US Adults Aged 18 to 64 Years With Self-reported Post–COVID-19 Condition. JAMA Network Open. 2023;6(4):e237455–e237455. doi: 10.1001/jamanetworkopen.2023.7455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Karpman M, Fiol O, Popkin SJ, McCorkell L, Waxman E, Morriss S. Employment and material hardship among adults with long COVID in December 2022. 2023. July 2023. https://www.urban.org/research/publication/employment-and-material-hardship-among-adults-long-covid-december-2022
  • 28.Feldstein LR, Edwards D, Cope JR, Hagen MB, Saydah S. Differences in Report of Post-COVID Conditions Among Adults Tested for SARS-CoV-2 by Race and Ethnicity: 2022 Porter Novelli SummerStyles Survey, U.S. AJPM Focus. Apr 2024;3(2):100181. doi: 10.1016/j.focus.2023.100181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Perlis RH, Santillana M, Ognyanova K, et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Network Open. 2022;5(10):e2238804–e2238804. doi: 10.1001/jamanetworkopen.2022.38804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Perlis RH, Trujillo KL, Safarpour A, et al. Research Letter: Association between long COVID symptoms and employment status. medRxiv. Nov 18 2022;doi: 10.1101/2022.11.17.22282452 [DOI] [Google Scholar]
  • 31.Miskowiak KW, Pedersen JK, Gunnarsson DV, et al. Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life. J Affect Disord. Mar 1 2023;324:162–169. doi: 10.1016/j.jad.2022.12.122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhao S, Martin EM, Reuken PA, et al. Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study. eClinicalMedicine. 2024/02/01/ 2024;68:102434. doi: 10.1016/j.eclinm.2024.102434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Substance Abuse and Mental Health Services Administration (SAMHSA). A Preliminary Look at the Mental Health and Substance Use-related Effects of the COVID-19 Pandemic (2021). Accessed 05/24/24, https://www.samhsa.gov/sites/default/files/dtac/mental-health-substance-use-effects-covid-pandemic-srb.pdf
  • 34.Blanchflower DG, Bryson A. Long COVID in the United States. PLoS One. 2023;18(11):e0292672. doi: 10.1371/journal.pone.0292672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Drieskens S, Demarest S, Bel S, De Ridder K, Tafforeau J. Correction of self-reported BMI based on objective measurements: a Belgian experience. Arch Public Health. 2018;76:10. doi: 10.1186/s13690-018-0255-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Connor Gorber S, Shields M, Tremblay MS, McDowell I. The feasibility of establishing correction factors to adjust self-reported estimates of obesity. Health Rep. Sep 2008;19(3):71–82. [PubMed] [Google Scholar]
  • 37.Hayes AJ, Kortt MA, Clarke PM, Brandrup JD. Estimating equations to correct self-reported height and weight: implications for prevalence of overweight and obesity in Australia. Australian and New Zealand Journal of Public Health. 2008/12/01/ 2008;32(6):542–545. doi: 10.1111/j.1753-6405.2008.00306.x [DOI] [PubMed] [Google Scholar]
  • 38.Scholes S, Ng Fat L, Moody A, Mindell JS. Does the use of prediction equations to correct self-reported height and weight improve obesity prevalence estimates? A pooled cross-sectional analysis of Health Survey for England data. BMJ Open. 2023;13(1):e061809. doi: 10.1136/bmjopen-2022-061809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Keramat SA, Alam K, Rana RH, et al. Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009–2017. PLoS One. 2021;16(11):e0260158. doi: 10.1371/journal.pone.0260158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ballouz T, Menges D, Anagnostopoulos A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Agergaard J, Gunst JD, Schiøttz-Christensen B, Østergaard L, Wejse C. Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants. Int J Infect Dis. Dec 2023;137:126–133. doi: 10.1016/j.ijid.2023.10.022 [DOI] [PubMed] [Google Scholar]
  • 42.Montoy JCC, Ford J, Yu H, et al. Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023. MMWR Morb Mortal Wkly Rep. Aug 11 2023;72(32):859–865. doi: 10.15585/mmwr.mm7232a2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ford ND, Slaughter D, Edwards D, et al. Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1–13, 2022, to June 7–19, 2023. MMWR Morb Mortal Wkly Rep. Aug 11 2023;72(32):866–870. doi: 10.15585/mmwr.mm7232a3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Martínez-Pozas O, Meléndez-Oliva E, Rolando LM, et al. The pulmonary rehabilitation effect on long covid-19 syndrome: A systematic review and meta-analysis. Physiother Res Int. 2024. Apr;29(2):e2077. doi: 10.1002/pri.2077. [DOI] [PubMed] [Google Scholar]
  • 45.Astin R, Banerjee A. Baker, et al. Long COVID: mechanisms, risk factors and recovery. Experimental Physiology, 2023, 108, 12–27. 10.1113/EP090802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bland AR, Barraclough M, Trender WR, et al. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals. Sci Rep. 2024. Jun 11;14(1):13368. doi: 10.1038/s41598-024-62050-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.American Academy of Physical Medicine and Rehabilitation. Multidisciplinary Quality Improvement Initiative: Published Guidance. https://www.aapmr.org/advocacy/current-priorities/long-covid-pasc/multidisciplinary-quality-improvement-initiative?utm_source=google&utm_medium=organic&utm_campaign=AAPMR Accessed 08/20/2024.
  • 48.Klok FA, Boon GJAM, Barco S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br J Psychiatry. Feb 2023;222(2):74–81. doi: 10.1192/bjp.2022.155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. Nov-Dec 2009;50(6):613–21. doi: 10.1176/appi.psy.50.6.613 [DOI] [PubMed] [Google Scholar]
  • 51.Jones JM, Manrique IM, Stone MS, et al. Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022. MMWR Morb Mortal Wkly Rep. Jun 2 2023;72(22):601–605. doi: 10.15585/mmwr.mm7222a3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Lundberg-Morris L, Leach S, Xu Y, et al. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ. 2023;383:e076990. doi: 10.1136/bmj-2023-076990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Xie Z, Stallings-Smith S, Patel S, Case S, Hong Y-R. COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population. Vaccine. 2024/06/11/ 2024;42(16):3529–3535. doi: 10.1016/j.vaccine.2024.04.070 [DOI] [PubMed] [Google Scholar]
  • 54.Yang C, Zhao H, Shannon CP, Tebbutt SJ. Omicron variants of SARS-CoV-2 and long COVID. Front Immunol. 2022;13:1061686. doi: 10.3389/fimmu.2022.1061686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Boufidou F, Medić S, Lampropoulou V, Siafakas N, Tsakris A, Anastassopoulou C. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic. International Journal of Molecular Sciences. 2023;24(16):12962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Greenhalgh T, MacIntyre CR, Baker MG, et al. Masks and respirators for prevention of respiratory infections: a state of the science review. Clinical Microbiology Reviews. 0(0):e00124–23. doi:doi: 10.1128/cmr.00124-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Izadyar N, Miller W. Ventilation strategies and design impacts on indoor airborne transmission: A review. Building and Environment. 2022/06/15/ 2022;218:109158. doi: 10.1016/j.buildenv.2022.109158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Edwards CH, Tomba GS, de Blasio BF. Influenza in workplaces: transmission, workers’ adherence to sick leave advice and European sick leave recommendations. Eur J Public Health. Jun 2016;26(3):478–85. doi: 10.1093/eurpub/ckw031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Packard SE, Susser E. Association of long COVID with housing insecurity in the United States, 2022–2023. SSM - Population Health. 2024/03/01/ 2024;25:101586. doi: 10.1016/j.ssmph.2023.101586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ford ND, Slaughter D, Dalton AF, et al. Health Insurance and Access to Care in U.S. Working Age Adults Experiencing Long COVID. American Journal of Preventive Medicine. 2024/05/17/ 2024;doi: 10.1016/j.amepre.2024.05.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. 2023;11:1170156. doi: 10.3389/fpubh.2023.1170156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Gollop C, Zingel R, Jacob L, Smith L, Koyanagi A, Kostev K. Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study. Journal of Alzheimer’s Disease. 2023;93:1033–1040. doi: 10.3233/JAD-221271 [DOI] [PubMed] [Google Scholar]
  • 63.Koyama AK, Imperatore G, Rolka DB, et al. Risk of Cardiovascular Disease After COVID-19 Diagnosis Among Adults With and Without Diabetes. J Am Heart Assoc. Jul 4 2023;12(13):e029696. doi: 10.1161/jaha.123.029696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Marjenberg Z, Leng S, Tascini C, et al. Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis. Scientific Reports. 2023/09/15 2023;13(1):15332. doi: 10.1038/s41598-023-42321-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Sanchez Jimenez B, Sterling T, Brown A, et al. Wastewater surveillance in the COVID-19 post-emergency pandemic period: A promising approach to monitor and predict SARS-CoV-2 surges and evolution. Heliyon. Nov 2023;9(11):e22356. doi: 10.1016/j.heliyon.2023.e22356 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplemental tables

RESOURCES